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Background: To determine the prevalence of Gestational Diabetes Mellitus (GDM) in urban and rural Tamil Nadu in
southern India, using the International Association of Diabetes and Pregnancy Study Groups (IADPSG) and the World
Health Organization (WHO) 1999 criteria for GDM.
Methods: A total of 2121 pregnant women were screened for GDM from antenatal clinics in government
primary health centres of Kancheepuram district (n = 520) and private maternity centres in Chennai city in Tamil
Nadu (n = 1601) between January 2013 to December 2014. Oral glucose tolerance tests (OGTT) were done after
an overnight fast of at least 8 h, using a 75 g glucose load and venous samples were drawn at 0, 1 and 2 h.
GDM was diagnosed using both the IADPSG criteria as well as the WHO 1999 criteria for GDM.
Results: The overall prevalence of GDM after adjusting for age, BMI, family history of diabetes and previous
history of GDM was 18.5 % by IADPSG criteria with no significant urban/rural differences (urban 19.8 % vs rural
16.1 %, p = 0.46). Using the WHO 1999 criteria, the overall adjusted prevalence of GDM was 14.6 % again with
no significant urban/rural differences (urban 15.9 % vs rural 8.9 %, p = 0.13).
Conclusion: The prevalence of GDM by IADPSG was high both using IADPSG as well as WHO 1999 criteria with
no significant urban/rural differences. This emphasizes the need for increasing awareness about GDM and for
prevention of GDM in developing countries like India.
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AsiansBackground
The prevalence of diabetes mellitus (DM) is increasing
worldwide and more so in developing countries such as
India [1, 2]. Along with the rising tide of the current epi-
demic of diabetes, the prevalence of gestational diabetes
mellitus (GDM), defined as any degree of glucose in-
tolerance with onset or first recognition during preg-
nancy, is also on the rise [3, 4]. GDM increases the risk
of complications in both the mother and child and early
detection and management improves outcomes for both* Correspondence: drmohans@diabetes.ind.in
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of hyperglycemia in pregnancy, of which 90 % were
GDM [6]. Racial/ethnic differences in the prevalence of
GDM have been documented, with a higher prevalence
among Native American, Asian, African-American, and
Hispanic populations compared to non-Hispanic Whites
[7]. GDM is usually asymptomatic and is most com-
monly diagnosed by routine screening during pregnancy.
Unfortunately, there is little agreement on the best
screening and diagnostic tests for GDM. The Inter-
national Association of Diabetes and Pregnancy Study
Group (IADPSG) criteria was introduced in the year
2010 and it has found fairly wide acceptance [8]. How-
ever, there have been some reports that it may lead toarticle is distributed under the terms of the Creative Commons Attribution 4.0
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paper, we report on the prevalence of GDM in urban
and rural Tamil Nadu in southern India using the
IADPSG criteria and compare the same with prevalence
rates obtained using the World Health Organization
(WHO) 1999 criteria for GDM.Methods
This study is part of the Women in India with GDM
Strategy (WINGS) project of the International Diabetes
Federation carried out in Chennai city (urban) and rural
antenatal clinics in Tamil Nadu in south India. The study
was conducted between January 2013 and December
2014. Consecutive pregnant women were screened at their
first booking at 15 government primary health centres in
Kancheepuram district and 6 private health centres at
Chennai city in Tamil Nadu state. Written informed
consent was obtained in the local language from all par-
ticipants and the study was approved by the Institu-
tional Ethics Committee of the Madras Diabetes
Research Foundation (MDRF). All procedures followed
were in accordance with the ethical standards and in
keeping with the Declaration of Helsinki 1975, as re-
vised in 2008. Permission was also obtained from the
Directorate of Public Health and the Ministry of
Health, Government of Tamil Nadu to conduct the
study in the primary health centres. Clinical informa-
tion including obstetric history, family history of dia-
betes as well as current and past medications was
collected using a structured questionnaire.
Height was measured using a stadiometer (SECA
Model 213, Seca Gmbh Co, Hamburg, Germany) to the
nearest 0.1 cm and weight was measured with an elec-
tronic weighing machine (SECA Model 803, Seca
Gmbh Co) to the nearest 0.1 kilogram. The body mass
index (BMI) was calculated as weight (kg) divided by
height (in metres) squared. Participants were requested
to report in the fasting state (at least 8 h of overnight
fasting), between 7 and 9 am on the day of blood col-
lection. A fasting venous sample was drawn for plasma
glucose estimations. 82.5 g of anhydrous glucose
(equivalent to 75 g of monohydrate glucose) was then
dissolved in 300 ml of water and was given to the preg-
nant women who consumed it within 5 min. Further
venous samples were drawn at 1 h and 2 h after the in-
gestion of oral glucose.
Plasma glucose (PG) was estimated by the glucose
oxidase–peroxidase method using autoanalyser AU2700
(Beckman, Fullerton, CA). Glycated haemoglobin (HbA1c)
was measured using high performance liquid chromatog-
raphy (HPLC) using Variant machine (BIORAD, Hercules,
CA). The intra and inter-assay coefficients of variation
(CV) for the glucose and HbA1c ranged from 0.78–1.68 %and 0.59–1.97 % respectively. All samples were proc-
essed in our laboratory which is certified by the College
of American Pathologists (CAP) and by the National
Accreditation Board for Testing and Calibration La-
boratories (NABL), Government of India.
Definitions
GDM was diagnosed by IADPSG criteria, if any one of
the fasting, 1 h or 2 h PG values met or exceeded
5.1 mmol/L (≥92 mg/dl), 10.0 mmol/L (≥180 mg/dl) and
8.5 mmol/L (≥153 mg/dl) [11] respectively. As per the
IADPSG criteria, in the first trimester, GDM was diag-
nosed using only the fasting glucose estimations, while
in 2nd/3rd trimester, GDM was diagnosed using an oral
glucose tolerance test (OGTT).
The World Health Organization (WHO) 1999 criteria
[12], which diagnoses GDM using 2 h PG value of
7.7 mmol/l (≥140 mg/dl) was applied to the results, to
compare the prevalence rates with those obtained using
the IADPSG criteria.
Statistical analysis
All analyses was done using Windows based SPSS statis-
tical package (version 15.0, Chicago, IL). Estimates were
expressed as mean ± standard deviation or proportions.
To compare continuous variables, t tests were used
while chi square tests were used to test differences in
proportions. P-value <0.05 was considered significant. A
multivariable logistic regression model was developed
to identify factors associated with gestational diabetes
using GDM diagnosis according to IADSPG criteria as
the dependent variable and independent variables were
chosen based on p value <0.2 in univariate analysis or
were clinically relevant.
Results
A total of 2507 consecutive pregnant women were
approached to participate in the WINGS screening
programme of whom 2121 consented (84.6 %) which
included 520 from rural, and 1601 from urban, cen-
tres. As shown in Fig. 1, a total of 488 women under-
went screening in the first trimester. GDM was
diagnosed in 48 women (9.8 %) using the IADPSG
criteria while 6 (1.2 %) had overt diabetes, i.e., fasting
PG ≥ 7 mmol/l (≥126 mg/dl) and/or HbA1c ≥6.5 %.
As part of WINGS protocol, in the pilot phase, we
did not expect women to return in the 2nd/3rd trimes-
ter for repeat OGTT unlike in the Model of Care
phase of WINGS where we followed women right
through the pregnancy. Nevertheless, of the remaining
434 women, 87 who screened negative in the first tri-
mester, returned for repeat OGTT in the 2nd/3rd tri-
mester. The rest (n = 347) who did not return for a
FIRST TRIMESTER 
SCREENING
Pregnant women screened n= 488
Overt diabetes: n= 6 (1.2%)
(fasting > 126 mg/dl and/or HbA1c 
>6.5)
GDM: n= 48 (9.8%)
(FPG between 92-125mg/dl)
NGT: n = 434 
(Fasting <92 mg/dl)
347 NGT women 















Overt diabetes: n= 7 (0.4%) 
(fasting > 126 mg/dl)
GDM: n= 221(13.5%) 
(FPG between 92-125mg/dl or 
1h >180mg/dl or 
2h >153mg/dl)
NGT: n = 1405 
(FPG <92mg/dl and
1h <180mg/dl and 
2h <153mg/dl)
GDM: 9 (10.3%)
(FPG between 92-125mg/dl 
or 
1h >180mg/dl or 
2h >153mg/dl)
NGT: n = 78 
(FPG <92mg/dl and 





87 NGT returned for screening in 
2nd/3rd trimester
Fig. 1 Schedule of the screening done in the first and 2nd/3rd trimester in this study
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from further analysis.
In the 2nd/3rd trimester, 1633 women who were not
screened in the first trimester were screened using the
IADPSG criteria. GDM was diagnosed in 221 (13.5 %)
women while 7 (0.4 %) women had overt diabetes.
Among the 87 women who had normal glucose toler-
ance (NGT) in the first trimester screening, 9 (10.3 %)
developed GDM in the second/third trimester.
In both urban and rural populations, prevalence of
GDM was significantly higher by the IADPSG criteria
when compared to the WHO 1999 criteria. Table 1
shows that the overall prevalence (unadjusted) of
GDM by the IADPSG criteria was 15.7 % (n = 278),
while in urban areas, it was 16.1 % and in rural areas,
14.4 % (p = 0.37). After adjusting for age, BMI, familyTable 1 Prevalence of gestational diabetes based on IADPSG








IADPSG Criteria 278 (15.7 %) 210 (16.1 %) 68 (14.4 %)
WHO 1999 criteria 186 (10.5 %) 161 (12.4 %) 25 (5.3 %)
Adjusted prevalence ratesa
IADPSG Criteria 18.5 % 19.8 % 16.1 %
WHO 1999 criteria 14.6 % 15.9 % 8.9 %
aAdjusted for age, BMI, family history of diabetes and previous history of GDMhistory of diabetes and previous history of GDM, the
overall prevalence by IADPSG criteria was 18.5 %
(urban 19.8 % vs rural 16.1 %, p = 0.46).
If the WHO 1999 criteria was used, the unadjusted
overall prevalence of GDM was 10.5 % (n = 186) [urban
12.4 % (n = 161) vs rural 5.3 % (n = 25), p < 0.001]. How-
ever, after adjusting for age, BMI, family history of dia-
betes and previous history of GDM, the urban/rural
differences disappeared using the WHO 1999 criteria
also (urban 15.9 % vs rural 8.9 %, p = 0.13).
Of the 278 women identified by IADPSG criteria, 121
(43.5 %) were picked up by the WHO 1999 criteria.
Conversely, of the 186 women identified by the WHO
1999 criteria, IADPSG picked up 121 (65.1 %) of GDM
(Fig. 2). Thus, 121 pregnant women were diagnosed by
both IADPSG and WHO 1999 criteria (agreement,
kappa = 0.45).
Table 2 shows the general characteristics of the 1774
study subjects in urban and rural areas. Women with
GDM in urban areas were significantly older, had higher
BMI and lower levels of fasting and HbA1c (p < 0.001)
compared to those in rural areas.
Multivariable logistic regression models were used to
identify factors associated with gestational diabetes
based on the IADPSG criteria (Table 3). The variables
that had a p value <0.2 in univariate analysis or were
clinically relevant were used in the multiple logistic re-
gression. HbA1c, previous history of GDM, family his-
tory of diabetes and age were significantly associated











Fig. 2 Venn diagram depicting the GDM identified by both criteria
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The study reports the following findings:
1. The prevalence of GDM based on the IADPSG
criteria, after adjusting for age, BMI, family history
of diabetes and previous history of GDM was 18.5 %
and based on the WHO 1999 criteria, it was 14.6 %.
2. The prevalence rates of GDM were not significantly
different between urban and rural areas both using
the IADPSG criteria and WHO 1999 criteria after
correcting for the confounders.
3. In the multivariable logistic regression, HbA1c,
previous history of GDM, family history of diabetes
and age were significantly associated with GDM.
Several criteria for diagnosing GDM have been rec-
ommended by various national and international bodies
including the American Diabetes Association (ADA),
Australasian Diabetes in Pregnancy Study Group (ADIPS),
Canadian Diabetes Association (CDA), European Associ-
ation for the study of Diabetes (EASD), International As-
sociation of the Diabetes and Pregnancy Study Groups
(IADPSG), International Classification of Diseases (ICD),
National Diabetes Data Group (NDDG), the World Health
Organization (WHO) and the Diabetes In India Pregnancy
Study Group of India (DIPSI). These criteria differ in their
requirement for the subject to be in a fasting state, the
number of samples needed, the amount of glucose admin-
istered and blood glucose thresholds for GDM detection
[13]. Not surprisingly, the prevalence rates of GDM also
vary according to the criteria used. In this paper, we report
on the prevalence of GDM by the IADPSG and the WHO
1999 criteria.
Comparing the prevalence rates with other GDM preva-
lence studies carried out globally using the IADPSG cri-
teria, a prevalence of 8.9 % has been reported in Sri Lanka
[14] and 2.6 % in Thailand [15] and between 2–6 % in Eur-
ope [16]. Using the WHO 1999 criteria, a prevalence of
7.2 % was reported in Sri Lanka [15], 9.7 % in Bangladesh
[17], 11.4 % in Malaysia [18], 20.6 % in United ArabEmirates [19] and 16.3 % in Qatar [20]. Table 4 summa-
rizes the prevalence of GDM reported in some of the
recent studies conducted worldwide [21–28].
Table 5 and Fig. 3 presents a review of various studies
on GDM prevalence carried out in India since 2004.
Using the Diabetes in Pregnancy Study Group of India
(DIPSI) criteria, which diagnoses GDM based on a non
fasting 2 h OGTT, a prevalence of 6.9 % was reported in
Jammu [29]. Using the ADA criteria, which recommends
a two step procedure, i.e., a 50 g glucose challenge test
followed by 100 g confirmatory OGTT, a prevalence of
7.1 % was reported in Haryana [30], 7.7 % in Maharash-
tra [9] and 8.1 % in Manipur [31] and 3.1 % in Kashmir
[32]. Using the IADPSG criteria, a high prevalence
(27 %) was reported in Puducherry [10]. Using WHO
1999 criteria, a prevalence of 16.5 % was reported in an
earlier study carried out in Chennai [33], and a preva-
lence of 4.4 % was reported in Kashmir [32]. Recent
studies from India by Arora et al. [34] have also reported
higher prevalence rates of GDM (34.9 %) using the
IADPSG criteria. Though their sample size was large,
the authors had used 2 h capillary measurements instead
of venous plasma samples albeit with adjustment for the
values. This might explain, at least partly, the differences
from our study.
The prevalence of GDM in our study was 26.7 %
higher by the IADPSG criteria compared to the WHO
1999 criteria. This is similar to the 25 % higher preva-
lence reported by O’Sullivan et al. [35] [IADPSG–12.4 %
vs. WHO–9.4 %]. In another study in Sri Lanka, the
prevalence of GDM was 23.6 % higher using IADPSG
compared to WHO 1999 criteria [15]. Studies from
China showed the prevalence to be higher by IADPSG
(19.9 %) when compared to ADA criteria (7.9 %) [36]. A
study from Taiwan [37] showed that the IADPSG criteria
increased the prevalence of GDM from 4.6 % (by ADA
criteria) to 12.4 %. A study from Canada reported an in-
crease in the rates of GDM from 7.9 % using ADA criteria
to 9.4 % if IADPSG criteria were used [38]. In Spain, ap-
plying the IADPSG criteria was associated with a 3.5-fold
increase in GDM prevalence [39]. The higher percentage
increase could perhaps to attributed to ethnic differences
in fasting hyperglycemia. Earlier studies have shown that
Asian Indians have higher fasting hyperglycemia com-
pared to Caucasians [40, 41]. Gopalakrishnan et al. [42]
reported 41.9 % prevalence of GDM in their study, of
whom 70.5 % had abnormal fasting blood glucose
alone. Nayak et al. [43] also showed that 63.8 % of
GDM identified by the IADPSG criteria had fasting
hyperglycemia. Another study by Moradi et al. [44]
showed that 48 % of GDM identified by IADPSG had
elevated fasting blood glucose levels alone. Results from
our study shows that even among Asian Indians, rural
women with GDM have higher fasting hyperglycemia.
Table 2 General characteristics of the GDM and non GDM diagnosed by IADPSG criteria in urban and rural areas














Age 26.2 ± 4.1 27.4 ± 4.3 25.9 ± 4.0 24 ± 2.9 23.9 ± 2.5 23.9 ± 3.0 <0.001 25.6 ± 3.9 26.5 ± 4.2 25.4 ± 3.8 0.0238
BMI 24.7 ± 4.9 26.2 ± 4.5 24.6 ± 4.9 22.1 ± 3.7 22.6 ± 3.9 22.1 ± 3.6 <0.001 24.2 ± 4.7 25.4 ± 4.6 24.0 ± 4.7 <0.001
Family history of T2DM 366 (28.1 %) 82 (39 %) 284 (26 %) 51 (10.8 %) 12 (17.6 %) 39 (9.6 %) <0.001 417 (23.5 %) 94 (33.8 %) 323 (21.6 %) 0.0001
Previous history of GDM 25 (1.9 %) 12 (5.7 %) 13 (1.2 %) 1 (0.2 %) 0 1 (0.2 %) <0.001 26 (1.5 %) 12 (4.3 %) 14 (0.9 %) 0.0062
Fasting (mg/dl) 80 ± 12.8 93 ± 10.4 77 ± 11.6 81 ± 12.4 96 ± 11.3 78 ± 10.5 0.1355 80.6 ± 12.6 94.1 ± 10.7 78.0 ± 11.3 <0.001
HbA1c (%) 4.9 ± 0.6 5.1 ± 0.5 4.8 ± 0.5 5.1 ± 0.6 5.3 ± 0.6 5.0 ± 0.4 <0.001 4.9 ± 0.53 5.1 ± 0.4 4.9 ± 0.5 <0.001
*p value comparing overall urban vs rural
**p value significant (<0.005), comparing GDM urban vs GDM rural











Table 3 Multivariable logistic regression showing factors
independently associated with gestational diabetes mellitus
diagnosed by IADPSG criteria
Variable Odds ratio (95 % CI), p value
HbA1c (at booking) 2.91 (1.69–3.12), p < 0.001
Previous history of GDM 3.63 (1.48–8.90), p = 0.005
Family history of diabetes 1.54 (1.11–2.15), p = 0.009
Age (at booking) 1.03 (1.00–1.08), p = 0.05
Body mass index (at booking) 1.02 (0.99–1.05), p = 0.14
Paritya 1.00 (0.74–1.35), p = 0.99
aPrimi mothers as reference
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significantly younger, less heavy, have less family history
of diabetes, their fasting plasma glucose levels and
HbA1c are higher compared to women with GDM in
urban area. This could account for the discrepancy be-
tween the prevalence rates by IADPSG and WHO 1999
criteria in the rural population. Given that the two cri-
teria identifies different sets of patients, omitting the
fasting criteria (as in the WHO 1999 criteria) wouldTable 4 Studies on prevalence of gestational diabetes mellitus–wor
Author Name City/Country
Agarwal et al. (2007) Al Ain, United Arab Emirates
Tan et al. (2007) Malaysia
Bener et al. (2011) Doha, Qatar
Moses et al. (2011) Australia
Dahanayaka et al. (2012) Sri Lanka
Jenum et al. (2012) Oslo, Norway
Kalter-Leibovivi et al. (2012) Israel
Reyes-Munoz E et al. (2012) Mexico
Kanjana et al. (2013) Thailand
Duran et al. (2014) Madrid, Spain
Shang et al. (2014) China
Liao et al. (2014) Chengdu, China
Leng et al. (2015) Tianjin, China
Hung et al. (2015) Taoyuan, China
Sibartie et al. (2015) Australia
Ethridge et al. (2015) Ohio, United States of America
O’Sullivan et al. (2016) Galway, Irelandtend to miss a lot of GDM cases especially in the rural
population.
It has also been shown that fasting hyperglycemia by
IADPSG criteria is associated with increased perinatal
complications [45]. The arguments in favor of using
IADPSG criteria are therefore based on pregnancy out-
comes, and early screening and diagnosis of GDM helps
to initiate treatment earlier (usually medical nutrition
therapy) [46, 47]. Thus, whereas on one hand, there is
indeed an increase in prevalence of GDM, on the other
hand, identifying more women and starting lifestyle
changes promises better outcomes [39].
A Sri Lankan study reported 51.1 % agreement be-
tween IADPSG and WHO 1999 criteria [15] which is
similar to the present study, where 45 % agreement
was noted.
We have earlier reported on the necessity for doing
fasting OGTTs for diagnosing GDM [48] and also on
the need for doing venous plasma samples [49]. In this
paper we report on fasting OGTTs using venous
plasma samples using both the IADPSG and WHO
1999 criteria.ldwide
Sample Size Prevalence Criteria used for GDM diagnosis
1172 20.6 % WHO 1999
1600 11.4 % WHO 1999




















































Table 5 Studies on prevalence of gestational diabetes mellitus in India
Author Name City/State Sample Size Prevalence Criteria used for GDM diagnosis
Seshiah et al. (2004) Government Maternity Hospital, Chennai 3674 16.5 % WHO 1999




Swami et al. (2008) Tertiary care hospital in Maharashtra 1225 7.7 % ADA 2005
Seshiah et al. (2011) Chennai, South India 1463 13.4 % DIPSI
Wahi et al. (2011) Govt Medical College Hospital, Jammu region 2025 6.9 % DIPSI
Nayak et al. (2013) Pondicherry Institute of Medical Science 304 27 % IADPSG
Vanlalhruaii et al. (2013) Regional Institute of Medical Sciences Manipur 300 8.1 % ADA 2005
Rajput et al. (2013) Post Graduate Institute of Medical Sciences
Haryana
607 7.1 % ADA 2005




Raja et al. (2014) Government Medical College Srinagar
Kashmir valley
306 7.8 % DIPSI




Kalyani et al. (2014) Central India 300 8.33 % WHO 1999




Gopalakrishnan V et al. (2015) Sanjay Gandhi Postgraduate Institute of
Medical Sciences, Lucknow, Uttar
Pradesh, India.
332 41.9 % IADPSG














Fig. 3 Graphical representation of GDM prevalence across India
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age, obesity, and family history of diabetes to be associ-
ated with GDM [3]. These findings are consistent with
the present study findings, which reveals that, HbA1c,
previous history of GDM, family history of diabetes and
age were found to be associated with GDM diagnosed
using the IADPSG criteria.
This study has several strengths: (i) both urban and
rural areas were sampled; (ii) large sample size; (iii) this
is one of the first studies from India to report on the dif-
ferences in prevalence of GDM by both IADPSG and
WHO 1999 criteria in urban/rural areas (iv) screening
was done during the first trimester and in the 2nd/3rd
trimester using the IADPSG criteria. Traditionally,
screening for GDM is delayed until 2nd or early 3rd tri-
mester since the diabetogenic effects of pregnancy in-
creases with gestational age, and delayed testing wouldmaximize the detection rate [50, 51]. However, early
identification gives time for appropriate intervention
which could help reduce complications. Moreover, as
shown in our study, screening in the first trimester also
provides an opportunity to detect previously undiag-
nosed overt diabetes as well as GDM. In our study, first
trimester screening identified 1.2 % of overt diabetes and
9.8 % GDM. A study from Trichy [52] recently reported
GDM prevalence of 13.9 % in first trimester. Data from
Oklahoma shows that among American Indians, preva-
lence of GDM and overt diabetes in first trimester was
24 % and 0.4 % respectively [53]. There is insufficient
data from India on the prevalence of overt diabetes in
the first trimester and hence the findings from this study
are significant. As per the recommendations of IADPSG
criteria, women who are labeled as having normal glu-
cose tolerance in the first trimester should undergo a
Bhavadharini et al. Clinical Diabetes and Endocrinology  (2016) 2:8 Page 9 of 11repeat OGTT in the 2nd/3rd trimester. However, in our
study, only 87 women of the 434 returned for repeat
OGTT which is one of the limitations of this study. A
recent study by Morikawa et al. [54] from Japan, showed
that women who were diagnosed as having normal glucose
tolerance (NGT) in the first trimester remained as NGT
throughout their pregnancy, despite the significant in-
crease in insulin resistance. In contrast, results from our
study shows that among those who returned for a repeat
screening (n = 87), 10.3 % developed GDM. Similar find-
ings emphasizing the need for repeat screening have been
reported earlier in Hungarian women, where the GDM
prevalence was noted to increase with advancing gestation
[55]. This therefore highlights the importance of repeat
screening among women who screened negative in the
first trimester in populations like ours which have a higher
risk for GDM. Another limitation of the study is that,
pregnant women included in the study were from a few
selected antenatal clinics in urban and rural areas in Tamil
Nadu and hence the results may not be representative of
the GDM rates in the country as a whole. Finally, there
were some significant differences between the 1774
women who participated and the 386 women who refused
to participate, which is yet another limitation (Additional
file: 1 Table S1).Conclusions
The prevalence of GDM in Tamil Nadu was found to be
15.7 % (adjusted 18.5 %) by IADPSG criteria and 10.5 %
(adjusted 14.6 %) using the WHO 1999 criteria. There
were no urban rural differences using both criteria sug-
gesting that the rural areas in southern India are also fast-
ing catching up with reference to rising GDM prevalence
rates. This emphasizes the need for increasing awareness
about GDM and taking steps to prevent GDM in India
and other developing countries.Ethical standard
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